Cancer Pathology Data Sharing
2.0.0 - STU 2

Cancer Pathology Data Sharing, published by HL7 International / Orders and Observations. This guide is not an authorized publication; it is the continuous build for version 2.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cancer-reporting/ and changes regularly. See the Directory of published versions

## Example Bundle: US Pathology Exchange bundle example

Document Details

Profile: US Pathology Bundle

Final Document at 2025-01-01 21:39:30+0000 by Wise Owl for Annie Oakley in encounter Encounter: identifier = http://example.com/fhir/encounters#123; status = finished; class = inpatient encounter (ActCode[9.0.0]#IMP); type = Pathology consultation, comprehensive, records and specimen with report

Document Subject

Profile: US Core Patient Profile

Annie Oakley Female, DoB: 1990-06-01 ( SHID: 12446 (use: usual, ))

Other Ids: | CaliforniaDLN/patient-OakleyAnnie FHIR/66574567 (use: usual, ) MRN/abc123 (use: usual, )
Contact Detail | ph: 1-(303)555-1212(Home) annie.oakley@example.com 4348 Main Street Denver CO 80111 US
Links: | Also see: RelatedPerson Bill Hickok

Document Content

## INVASIVE CARCINOMA OF THE BREAST: Resection

Specimen

Procedure

✓ Needle biopsy
__ Fine needle aspiration
__ Other (specify): ___________________
__ Not specified

Specimen Laterality

__ Right
✓ Left
__ Not specified

+Tumor Site (select all that apply)

__ Upper outer quadrant
__ Lower outer quadrant
__ Upper inner quadrant
__ Lower inner quadrant
__ Central
__ Nipple
✓ Clock position

Specify Clock Position (select all that apply)

__ 1 o'clock
__ 2 o'clock
__ 3 o'clock
__ 4 o'clock
__ 5 o'clock
__ 6 o'clock
__ 7 o'clock
✓ 8 o'clock
__ 9 o'clock
__ 10 o'clock
__ 11 o'clock
__ 12 o'clock

__ Specify distance from nipple in Centimeters (cm): _______________ cm
__ Other (specify): ___________________
__ Not specified

Histologic Type (Note A)

__ No residual invasive carcinoma
✓ Invasive carcinoma of no special type (ductal)
__ Micro-invasive carcinoma
__ Invasive lobular carcinoma
__ Invasive carcinoma with mixed ductal and lobular features
__ Invasive carcinoma with features of (specify): ___________________
__ Tubular carcinoma
__ Invasive cribriform carcinoma
__ Mucinous carcinoma
__ Invasive micropapillary carcinoma
__ Apocrine adenocarcinoma
__ Metaplastic carcinoma
__ Encapsulated papillary carcinoma with invasion
__ Solid papillary carcinoma with invasion
__ Intraductal papillary adenocarcinoma with invasion
__ Adenoid cystic carcinoma
__ Neuroendocrine tumor
__ Neuroendocrine carcinoma
__ Invasive carcinoma, type cannot be determined: ___________________
__ Other histologic type not listed (specify): ___________________
__ Histologic Type Comment: ___________________

Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note B)

__ Not applicable (no residual carcinoma or microinvasion only)
✓ Nottingham Score

Glandular (Acinar) / Tubular Differentiation

✓ Score 1 (greater than 75% of tumor area forming glandular / tubular structures)
__ Score 2 (10% to 75% of tumor area forming glandular / tubular structures)
__ Score 3 (less than 10% of tumor area forming glandular / tubular structures)
__ Score cannot be determined

Nuclear Pleomorphism

__ Score 1 (Nuclei small with little increase in size in comparison with normal breast epithelial cells, regular outlines, uniform nuclear chromatin, little variation in size)
✓ Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)
__ Score 3 (Vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and shape, occasionally with very large and bizarre forms)
__ Score cannot be determined

Mitotic Rate

See Table 1 in CAP Protocol
✓ Score 1
__ Score 2
__ Score 3
__ Score cannot be determined: ___________________

Overall Grade

✓ Grade 1 (scores of 3, 4, or 5)

Tumor Size (Note E)

__ No residual invasive carcinoma
__ Microinvasion only (less than or equal to 1 mm)
✓ Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm)): 13.0 mm
__ Additional Dimension in Millimeters (mm): ____ × ____ mm
__ Size of largest invasive focus cannot be determined (explain): ___________________

+Tumor Focality (Note F)

✓ Single focus of invasive carcinoma
__ Multiple foci of invasive carcinoma
__ Number of Foci
__ Specify number: ___________________
__ At least: ___________________
__ Cannot be determined

Ductal Carcinoma In Situ (DCIS) (Note G)

✓ Not identified
__ Present
__ Present (in close proximity to invasive carcinoma)
__ Present only after presurgical therapy and prior to therapy the cancer is classified as pTis
__ Negative for extensive intraductal component (EIC)
__ Positive for extensive intraductal component (EIC)
__ Only DCIS is present after presurgical (neoadjuvant) therapy

+Size (Extent) of DCIS

__ Estimated size (extent) of DCIS is at least in Millimeters (mm): _____ mm
__ Additional Dimension in Millimeters (mm): _____ × _____ mm
__ Cannot be determined

Tumor Extent (Note H)

__ Tumor Extent (required only if skin, nipple, or skeletal muscle are present and involved) (select all that apply)
✓ Not applicable (skin, nipple, and skeletal muscle are absent OR are uninvolved)

Margin Status for Invasive Carcinoma (required only if residual invasive carcinoma is present in specimen)

__ Not applicable (residual invasive carcinoma in specimen is absent)
✓ All margins negative for invasive carcinoma

Distance from Invasive Carcinoma to Closest Margin

Specify in Millimeters (mm):

✓ Exact distance: ______________ mm
__ Less than: ______________ mm
__ Greater than: ______________ mm
__ Other (specify): ______________
__ Cannot be determined (explain): ______________

+Closest Margin(s) to Invasive Carcinoma (select all that apply)

__ Anterior
__ Posterior
__ Superior
__ Inferior
__ Medial
✓ Lateral
__ Other (specify): ______________
__ Cannot be determined (explain): ______________

Margin(s) Involved by Invasive Carcinoma (select all that apply)

__ Anterior (specify extent): ______________
__ Posterior (specify extent): ______________
__ Superior (specify extent): ______________
__ Inferior (specify extent): ______________
__ Medial (specify extent): ______________
__ Lateral (specify extent): ______________
__ Other (specify margin(s) and extent): ______________
__ Cannot be determined (explain): ______________
__ Other (specify): ______________
__ Cannot be determined (explain): ______________

Regional Lymph Node Status

__ Not applicable (no regional lymph nodes submitted or found)
✓ Regional lymph nodes present
__ All regional lymph nodes negative for tumor
__ Tumor present in regional lymph node(s)

Number of Lymph Nodes with Macrometastases (greater than 2 mm)

__ Exact number (specify): ______________
__ At least (specify): ______________
__ Other (specify): ______________
__ Cannot be determined (explain): ______________

Number of Lymph Nodes with Micrometastases (greater than 0.2 mm to 2 mm and / or greater than 200 cells)

__ Exact number (specify): ______________
__ At least (specify): ______________
__ Other (specify): ______________
__ Cannot be determined (explain): ______________

Number of Lymph Nodes with Isolated Tumor Cells (0.2 mm or less OR 200 cells or less) (required only if applicable)

__ Not applicable
__ Exact number (specify): ______________
__ At least (specify): ______________
__ Other (specify): ______________
__ Cannot be determined (explain): ______________

Size of Largest Nodal Metastatic Deposit

Specify in Millimeters (mm):

__ Exact size: ______________ mm
__ Less than: ______________ mm
__ Greater than: ______________ mm
__ Other (specify): ______________
__ Cannot be determined (explain): ______________

Extranodal Extension

__ Not identified
__ Present, 2 mm or less
__ Present, greater than 2 mm

+Specify Amount:

__ Present
__ Cannot be determined: ______________
__ Other (specify): ______________
__ Cannot be determined (explain): ______________

Total Number of Lymph Nodes Examined (sentinel and non-sentinel)

✓ Exact number (specify): ______________
__ At least (specify): ______________
__ Other (specify): ______________
__ Cannot be determined (explain): ______________

Number of Sentinel Nodes Examined (if applicable)

__ Not applicable
✓ Exact number (specify): ______________
__ At least (specify): ______________
__ Other (specify): ______________
__ Cannot be determined (explain): ______________

Distant Site(s) Involved, if applicable (select all that apply)

✓ Not applicable
__ Non-regional lymph node(s) (specify, if possible): ______________
__ Lung: ______________
__ Liver: ______________
__ Bone: ______________
__ Brain: ______________
__ Other (specify): ______________
__ Cannot be determined

Modified Classification (required only if applicable) (select all that apply)

__ Not applicable
__ y (post-neoadjuvant therapy)
__ r (recurrence)

pT Category

__ pT not assigned (cannot be determined based on available pathological information)
__ pT0: No evidence of primary tumor
__ pTis (DCIS): Ductal carcinoma in situ
__ pTis (Paget): Paget disease NOT associated with invasive carcinoma and / or carcinoma in situ (DCIS) in the underlying breast parenchyma
__ pT1: Tumor less than or equal to 20 mm in greatest dimension
__ pT1mi: Tumor less than or equal to 1 mm in greatest dimension
__ pT1a: Tumor greater than 1 mm but less than or equal to 5 mm in greatest dimension
✓ pT1b: Tumor greater than 5 mm but less than or equal to 10 mm in greatest dimension
__ pT1c: Tumor greater than 10 mm but less than or equal to 20 mm in greatest dimension
__ pT2: Tumor greater than 20 mm but less than or equal to 50 mm in greatest dimension
__ pT3: Tumor greater than 50 mm in greatest dimension
__ pT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules)
__ pT4a: Extension to the chest wall; invasion of or adherence to pectoralis muscle in the absence of invasion of chest wall structures does not qualify as T4
__ pT4b: Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d'orange) of the skin which do not meet the criteria for inflammatory carcinoma
__ pT4c: Both T4a and T4b are present
__ pT4d: Inflammatory carcinoma
__ pT4 (subcategory cannot be determined)

pN Category

__ pN not assigned (no nodes submitted or found)
__ pN not assigned (cannot be determined based on available pathological information)
✓ pN0: No regional lymph node metastasis identified or ITCs only
__ pN0 (i+): ITCs only (malignant cell clusters no larger than 0.2 mm) in regional lymph node(s)
__ pN0 (mol+): Positive molecular findings by reverse transcriptase polymerase chain reaction (RT-PCR); no ITCs detected
__ pN1: Metastases in 1 to 3 axillary lymph nodes, at least one metastasis larger than 2.0 mm
__ pN1mi: Micrometastases (approximately 200 cells, larger than 0.2 mm, but none larger than 2.0 mm)
__ pN1a: Metastases in 1 to 3 axillary lymph nodes, at least one metastasis larger than 2.0 mm
__ pN1b: Metastases in internal mammary sentinel nodes, excluding ITCs
__ pN1c: pN1a and pN1b combined
__ pN2: Metastases in 4-9 axillary lymph nodes; or in clinically detected internal mammary lymph nodes with negative axillary nodes
__ pN2a: Metastases in 4-9 axillary lymph nodes (at least one tumor deposit larger than 2.0 mm)
__ pN2b: Metastases in clinically detected internal mammary lymph nodes with or without microscopic confirmation; with pathologically negative axillary lymph nodes
__ pN3: Metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or in clinically detected ipsilateral internal mammary lymph nodes with one or more positive level I, II axillary lymph nodes; or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease or macroscopic disease detected by sentinel lymph node biopsy but not clinically detected; or in ipsilateral supraclavicular lymph nodes
__ pN3a: Metastases in 10 or more axillary lymph nodes (at least one tumor deposit larger than 2.0 mm); or metastases to the infraclavicular (level III axillary lymph) nodes
__ pN3b: pN1a or pN2a in the presence of cN2b (positive internal mammary nodes by imaging); or pN2a in the presence of pN1b
__ pN3c: Metastases in ipsilateral supraclavicular lymph nodes

N Suffix (required only if applicable)

__ Not applicable
__ (sn) Sentinel node(s) evaluated. If 6 or more nodes (sentinel or nonsentinel) are removed, this modifier should not be used
__ (f) Nodal metastasis confirmed by fine needle aspiration or core needle biopsy
__ (m) Multiple primary synchronous tumors in a single organ

ADDITIONAL FINDINGS (Note O)

+Additional Findings (specify): ________________

SPECIAL STUDIES

The CAP Breast Biomarker Template should be used for reporting biomarkers requested for this resection specimen. Pending biomarker studies should be listed in the Comments section of this report.

+Breast Biomarker Studies Performed on Previous Biopsy (select all that apply)

✓ Estrogen Receptor (ER)

Estrogen Receptor (ER) Status

__ Positive (greater than 10% of cells demonstrate nuclear positivity)
__ Low Positive (1-10% of cells with nuclear positivity)
__ Negative
✓ Cannot be determined (indeterminate)

__ Progesterone Receptor (PgR)

✓ HER2 (by immunohistochemistry)

✓ Negative (Score 0)
__ Negative (Score 1+)
__ Equivocal (Score 2+)
__ Positive (Score 3+)
__ Cannot be determined (indeterminate)

__ HER2 (by in situ hybridization)

## Additional Resources Included in Document

Entry 2 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/DiagnosticReport/diagnosticreport-breast-invasive-carcinoma

Resource DiagnosticReport:

> Profile: US Pathology Diagnostic Report

> ## Pathology Synoptic report (Pathology)

> Subject | Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))
> When For | 2025-03-18 21:39:30+0000
> Performer | PractitionerRole Primary Interpreter
> Identifier | CAPeCC/urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995

> Report Details

> Code | Value | Flags | When For
> SPECIMEN |  | Final | 2025-03-18
> TUMOR |  | Final | 2024-12-05
> Tumor Extent (Note H) |  | Final | 2025-03-18 14:52:02+0000 --> (ongoing)
> Lymph Nodes |  | Final | 2025-03-18
> MARGINS (Note L) |  | Final | 2025-03-18
> REGIONAL LYMPH NODES (Note M) |  | Final | 2025-03-18
> Distant Metastasis |  | Final | 2025-03-18
> PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M) |  | Final | 2025-03-18
> ADDITIONAL FINDINGS (Note N) |  | Final | 2025-03-18
> SPECIAL STUDIES |  | Final | 2025-03-18
> COMMENTS |  | Final | 2025-03-18

Entry 3 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-specimen

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:6ac70450-cc74-4a8e-8699-9ffab1e0ac24

> status: Final

> category: Section

> code: SPECIMEN

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> hasMember:

> - Observation Procedure (Note A)
> - Observation Specimen Laterality

Entry 4 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-tumor

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85

> status: Final

> category: Section

> code: TUMOR

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2024-12-05

> performer: Practitioner Wise Owl

> hasMember:

> - Observation Tumor Site (Note B)
> - Observation Histologic Type (Note C)
> - Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)
> - Observation Tumor Size (Note E)
> - Observation Tumor Focality (Note F)
> - Observation Ductal Carcinoma In Situ (DCIS) (Note G)

Entry 5 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-lymph-nodes

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f

> status: Final

> category: Section

> code: Lymph Nodes

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

Entry 6 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-margins

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f

> status: Final

> category: Section

> code: MARGINS (Note L)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> hasMember: Observation Margin Status for Invasive Carcinoma

Entry 7 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-regional-lymph-nodes

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f

> status: Final

> category: Section

> code: REGIONAL LYMPH NODES (Note M)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> hasMember: Observation Regional Lymph Node Status

Entry 8 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-distant-metastasis

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f

> status: Final

> category: Section

> code: Distant Metastasis

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> hasMember: Observation DISTANT METASTASIS

Entry 9 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-ptnm-classification

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:4958b036-f88e-470b-b225-38e9fe6b6541

> status: Final

> category: Section

> code: PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> hasMember:

> - Observation pT Category
> - Observation pN Category

Entry 10 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-additional-findings

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995

> status: Final

> category: Section

> code: ADDITIONAL FINDINGS (Note N)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> hasMember: Observation Additional Findings (specify)

Entry 11 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-additional-findings-specify

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:9cfaa1f6-f0af-4e66-8fe0-130b2143b135

> status: Final

> category: Question

> code: Additional Findings (specify)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> derivedFrom: Observation ADDITIONAL FINDINGS (Note N)

Entry 12 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-special-studies

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:87335ed1-f468-4061-a401-8b8e3b54cf4c

> status: Final

> category: Section

> code: SPECIAL STUDIES

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> hasMember: Observation Breast Biomarker Testing Performed on Previous Biopsy

Entry 13 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-comments

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/uuid:c3189cd4-33a0-447f-9bbf-2b225e2aa305

> status: Final

> category: Section

> code: COMMENTS

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

Entry 14 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-procedure-breast-excision

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:7c9139fe-ddd5-49d9-b649-f37344e8b995

> status: Final

> category: Question

> code: Procedure (Note A)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Excision (less than total mastectomy)

> derivedFrom: Observation SPECIMEN

Entry 15 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-specimen-laterality

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:4bcd147c-ff3d-4eb3-bcd3-9d679bd1ad1b

> status: Final

> category: Question

> code: Specimen Laterality

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Right

> derivedFrom: Observation SPECIMEN

Entry 16 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-tumor-site

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:79ab15c8-4b0e-48e5-a477-7f72e62c002b

> status: Final

> category: Question

> code: Tumor Site (Note B)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> hasMember: Observation Clock position

> derivedFrom: Observation TUMOR

Entry 17 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-clock-position

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:ab9326c2-e1fe-4ba0-873c-41c923c7f772

> status: Final

> category: Question

> code: Clock position

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Clock position

> hasMember: Observation Specify Clock Position

> derivedFrom: Observation Tumor Site (Note B)

Entry 18 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-clock-position-8

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:bf778f95-b1a8-4674-a73e-1f2dc0bfbdc4

> status: Final

> category: Question

> code: Specify Clock Position

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-13 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: 8 o'clock

Entry 19 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-histologic-type

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85

> status: Final

> category: Question

> code: Histologic Type (Note C)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> value: Invasive carcinoma of no special type (ductal)

Entry 20 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-histologic-grade

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:cb7657fb-8127-41ef-9912-8f6fc52a5f85

> status: Final

> category: Question

> code: Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Nottingham Score

> hasMember:

> - Observation Glandular (Acinar) / Tubular Differentiation
> - Observation Nuclear Pleomorphism
> - Observation Mitotic Rate
> - Observation Overall Grade

> derivedFrom: Observation TUMOR

Entry 21 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-glandular-differentiation

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:f0d0b23b-f6a0-44d4-bfaf-ade1b485c0b0

> status: Final

> category: Question

> code: Glandular (Acinar) / Tubular Differentiation

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Score 2 (10 to 75% of tumor area forming glandular / tubular structures)

> derivedFrom: Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)

Entry 22 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-nuclear-pleomorphism

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:77d0563d-3685-4316-9a81-fa7d04d0d8d2

> status: Final

> category: Question

> code: Nuclear Pleomorphism

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)

> derivedFrom: Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)

Entry 23 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-mitotic-rate

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:814dd523-9284-4edb-8831-fc1c440e4979

> status: Final

> category: Question

> code: Mitotic Rate

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Score 1

> derivedFrom: Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)

Entry 24 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-overall-grade

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:ddea4bbc-a3e7-477b-b279-57cf5071e0b9

> status: Final

> category: Question

> code: Overall Grade

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2024-12-05 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Grade 1 (scores of 3, 4 or 5)

> derivedFrom: Observation Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)

Entry 25 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-tumor-size

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:66153175-f304-443e-99cb-4058f350248b

> status: Final

> category: Question

> code: Tumor Size (Note E)

> subject: Annie Oakley

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: PractitionerRole Primary Interpreter

> value: Greatest dimension of largest invasive focus greater than 1 mm (specify exact measurement in Millimeters (mm))

> hasMember: Observation Additional Dimension in Millimeters (mm)

> derivedFrom: Observation TUMOR

Entry 26 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-additional-dimension

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:18c9ea9c-ddf2-400d-adea-07c97dd7b016

> status: Final

> category: Question

> code: Additional Dimension in Millimeters (mm)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: 13

> derivedFrom: Observation Tumor Size (Note E)

Entry 27 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-tumor-focality

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:309f8a1c-8311-4751-8718-4b2573a09633

> status: Final

> category: Question

> code: Tumor Focality (Note F)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Single focus of invasive carcinoma

> derivedFrom: Observation TUMOR

Entry 28 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-ductal-carcinoma

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:c2f916f9-7438-4ba6-9cba-9e9064edbe3c

> status: Final

> category: Question

> code: Ductal Carcinoma In Situ (DCIS) (Note G)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Not identified

> derivedFrom: Observation TUMOR

Entry 29 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-section-tumor-extent

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:1dc64a64-e4f1-4996-87df-28b76446c35a

> status: Final

> category: Section

> code: Tumor Extent (Note H)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> derivedFrom: Observation TUMOR

Entry 30 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-margins-margin-status-for-invasive-carcinoma

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:ee170d9a-d5b5-481a-ac58-52dea11955b4

> status: Final

> category: Question

> code: Margin Status for Invasive Carcinoma

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: All margins negative for invasive carcinoma

> hasMember:

> - Observation Distance from Invasive Carcinoma to Closest Margin
> - Observation Closest Margin(s) to Invasive Carcinoma

> derivedFrom: Observation MARGINS (Note L)

Entry 31 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-margins-distance-to-closest-margin

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:7069b59e-9414-4838-bd6d-674ef97c414c

> status: Final

> category: Question

> code: Distance from Invasive Carcinoma to Closest Margin

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Exact distance

> derivedFrom: Observation Margin Status for Invasive Carcinoma

Entry 32 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-margins-closest-margin-to-invasive-carcinoma

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:c12982a8-541c-469a-b016-9468d58eb858

> status: Final

> category: Question

> code: Closest Margin(s) to Invasive Carcinoma

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18 14:52:02+0000 --> (ongoing)

> performer: Practitioner Wise Owl

> value: Lateral

> derivedFrom: Observation MARGINS (Note L)

Entry 33 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-regional-lymph-node-status

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f

> status: Final

> category: Question

> code: Regional Lymph Node Status

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> value: Regional lymph nodes present

> hasMember:

> - Observation Total Number of Lymph Nodes Examined (sentinel and non-sentinel)
> - Observation Number of Sentinel Nodes Examined

> derivedFrom: Observation REGIONAL LYMPH NODES (Note M)

Entry 34 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-regional-lymph-nodes-number-examined

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:a903ae85-913a-4c9b-94cb-c6a1e00340e3

> status: Final

> category: Question

> code: Total Number of Lymph Nodes Examined (sentinel and non-sentinel)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> value: Exact number (specify)

> derivedFrom: Observation Regional Lymph Node Status

Entry 35 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-regional-lymph-nodes-number-sentinel

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:25b43d87-bad0-4779-91c8-352ad2f778ce

> status: Final

> category: Question

> code: Number of Sentinel Nodes Examined

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> value: Exact number (specify)

> derivedFrom: Observation Regional Lymph Node Status

Entry 36 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-distant-metastasis

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f

> status: Final

> category: Section

> code: DISTANT METASTASIS

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> hasMember: Observation Distant Site(s) Involved, if applicable

Entry 37 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-distant-metastasis-distant-sites

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:a0d2cb8e-ab6f-4efe-ad2b-03c20d625a9f

> status: Final

> category: Question

> code: Distant Site(s) Involved, if applicable

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> value: Not applicable

> derivedFrom: Observation DISTANT METASTASIS

Entry 38 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-ptnm-classification-pT-Category

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:4958b036-f88e-470b-b225-38e9fe6b6541

> status: Final

> category: Question

> code: pT Category

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> value: pT1b: Tumor greater than 5 mm but less than or equal to 10 mm in greatest dimension

> derivedFrom: Observation PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)

Entry 39 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-ptnm-classification-pN-Category

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:7164b3a9-3061-4f7f-9bbb-2a4e6980d665

> status: Final

> category: Question

> code: pN Category

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> value: pN0: No regional lymph node metastasis identified or ITCs only#

> derivedFrom: Observation PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition) (Note M)

Entry 40 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-special-studies-breast-biomarker

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:3a313831-c8c5-44e7-8df2-af1b47b9879f

> status: Final

> category: Question

> code: Breast Biomarker Testing Performed on Previous Biopsy

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> hasMember:

> - Observation Estrogen Receptor (ER)
> - Observation HER2 (by immunohistochemistry)

> derivedFrom: Observation SPECIAL STUDIES

Entry 41 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-special-studies-estrogen-receptor

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:8e615e45-6a49-46d9-8dfe-e84f19c29a92

> status: Final

> category: Question

> code: Estrogen Receptor (ER)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-05

> performer: Practitioner Wise Owl

> value: Estrogen Receptor (ER)

> hasMember: Observation Estrogen Receptor (ER) Status

> derivedFrom: Observation Breast Biomarker Testing Performed on Previous Biopsy

Entry 42 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-special-studies-estrogen-receptor-status

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:32bd9a78-878b-4fda-a6bd-c0bc58109fe7

> status: Final

> category: Question

> code: Estrogen Receptor (ER) Status

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> value: Cannot be determined (indeterminate)

> derivedFrom: Observation Estrogen Receptor (ER)

Entry 43 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-special-studies-her2

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:deacb965-18d3-4451-a27f-0e26e7a9e5a2

> status: Final

> category: Question

> code: HER2 (by immunohistochemistry)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Stains Alot

> hasMember: Observation HER2 (by immunohistochemistry)

> derivedFrom: Observation Breast Biomarker Testing Performed on Previous Biopsy

Entry 44 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Observation/observation-special-studies-negative

Resource Observation:

> Profile: US Pathology Observation

> identifier: CAPeCC/urn:uuid:1ca2fb51-1752-4489-a4b0-5c0dccc043e5

> status: Final

> category: Question

> code: HER2 (by immunohistochemistry)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> effective: 2025-03-18

> performer: Practitioner Wise Owl

> value: Negative (Score 0)

> derivedFrom: Observation HER2 (by immunohistochemistry)

Entry 45 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Specimen/specimen-breast

Resource Specimen:

> Profile: US Pathology Specimen

> identifier: `https://www.example.org/some-lis/fhir/specimen-identifier-provisioner`/987654321

> accessionIdentifier: `https://www.example.org/some-lis/fhir/specimen-identifier-provisioner`/987654321X

> type: Tissue specimen (specimen)

> request: ServiceRequest Surgical pathology study

> ### Collections

> - | Collected[x] | Method | BodySite
> * | 2025-03-18 17:00:14-0500 | Excision (procedure) | No display for Specimen.collection.bodySite (concept: Breast structure (body structure))

> > container

Entry 46 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Patient/patient-OakleyAnnie

Resource Patient:

> Profile: US Core Patient Profile

> Annie Oakley Female, DoB: 1990-06-01 ( SHID: 12446 (use: usual, ))

> Other Ids: | CaliforniaDLN/patient-OakleyAnnie FHIR/66574567 (use: usual, ) MRN/abc123 (use: usual, )
> Contact Detail | ph: 1-(303)555-1212(Home) annie.oakley@example.com 4348 Main Street Denver CO 80111 US
> Links: | Also see: RelatedPerson Bill Hickok

Entry 47 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Encounter/encounter-uspath-specimen-collection

Resource Encounter:

> Profile: US Core Encounter Profileversion: null6.1.0)

> identifier: `http://example.com/fhir/encounters`/123

> status: completed

> class: inpatient encounter

> type: Pathology consultation, comprehensive, records and specimen with report

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> basedOn: ServiceRequest Surgical pathology study

> > participant

> > participant

Entry 48 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/ServiceRequest/servicerequest-cancer-path

Resource ServiceRequest:

> Profile: US Pathology Service Request

> status: Active

> intent: Order

> category: Pathology

> code: No display for ServiceRequest.code (concept: Surgical pathology study)

> subject: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> encounter: Encounter: identifier = http://example.com/fhir/encounters#123; status = finished; class = inpatient encounter (ActCode[9.0.0]#IMP); type = Pathology consultation, comprehensive, records and specimen with report

> occurrence: 2025-03-18 17:00:14-0500

> requester: PractitionerRole Ordering Provider

> specimen: Specimen: identifier = https://www.example.org/some-lis/fhir/specimen-identifier-provisioner#987654321; accessionIdentifier = https://www.example.org/some-lis/fhir/specimen-identifier-provisioner#987654321X; type = Tissue specimen (specimen)

Entry 49 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/PractitionerRole/practitionerrole-uspath-practitioner-oncologist

Resource PractitionerRole:

> Profile: US Pathology Related Practitioner Role

> practitioner: Practitioner Wise Owl

> organization: Organization Redwood Women's Center, P.C.

> code: Ordering Provider

Entry 50 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/PractitionerRole/practitionerrole-uspath-pathologist

Resource PractitionerRole:

> Profile: US Pathology Related Practitioner Role

> practitioner: Practitioner Stains Alot

> organization: Organization Some Pathology Lab Name

> code: Primary Interpreter

Entry 51 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/PractitionerRole/practitionerrole-uspath-surgeon

Resource PractitionerRole:

> Profile: US Pathology Related Practitioner Role

> practitioner: Practitioner Cuts Alot

> organization: Organization Redwood Women's Center, P.C.

> code: Ordering Provider

Entry 52 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Organization/organization-Redwood-Womens-Center-PC

Resource Organization:

> Profile: US Core Organization Profile

> active: true

> name: Redwood Women's Center, P.C.

> ### Contacts

> - | Address
> * | 3307 Renner Drive Fortuna CA 95540 USA

Entry 53 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Organization/organization-principal-pathology-lab

Resource Organization:

> Profile: US Core Organization Profile

> active: true

> name: Some Pathology Lab Name

> ### Contacts

> - | Address
> * | Any City CA 95540 USA

Entry 54 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Practitioner/practitioner-pathologist

Resource Practitioner:

> Profile: US Core Practitioner Profile

> identifier: NPI/1234567893

> name: Stains Alot

Entry 55 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Practitioner/practitioner-oncologist

Resource Practitioner:

> Profile: US Core Practitioner Profile

> identifier: NPI/1234567893

> name: Wise Owl

Entry 56 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/Practitioner/practitioner-surgeon

Resource Practitioner:

> Profile: US Core Practitioner Profile

> identifier: NPI/1234567893

> name: Cuts Alot

Entry 57 - fullUrl = http://hl7.org/fhir/us/cancer-reporting/RelatedPerson/relatedperson-pathology-next-of-kin

Resource RelatedPerson:

> Profile: US Core RelatedPerson Profile

> active: true

> patient: Annie Oakley Female, DoB: 1990-06-01 ( MRN: AlaskaDLN#abc123 (use: usual, ))

> relationship: Next-of-Kin

> name: Bill Hickok

> telecom: ph: 1-989-654-7896